Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York.
Infant
Infant, Newborn
Pregnancy
Female
Child
Humans
Hepacivirus
/ genetics
HIV Infections
/ complications
New York
/ epidemiology
Pregnancy Complications, Infectious
/ diagnosis
Retrospective Studies
Hepatitis C
/ diagnosis
Infectious Disease Transmission, Vertical
/ prevention & control
RNA, Viral
Exposure
Hepatitis C
Infant
Infection
Screening
Vertical transmission
Western New York
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
17 Jul 2023
17 Jul 2023
Historique:
received:
01
01
2023
accepted:
04
07
2023
medline:
19
7
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
Vertical transmission of hepatitis C virus (HCV) is the primary cause of hepatitis C in the pediatric population. Nonetheless, only a small proportion of HCV-exposed children are tested. This study aimed to measure the proportion of HCV-exposed children tested and infected in Western New York and to identify factors influencing the odds of testing and infection in this population. This was a 11-year retrospective chart review study in which clinical, demographic, and behavioral data for HCV-exposed children and their mothers were collected. This period included year 2019 when a hepatitis C program began promoting early hepatitis C screening among infants born to mothers positive for hepatitis C. PCR-based detection of hepatitis C was used for children under 18 months of age and antibody testing for children above 18 months of age, followed by PCR if the antibody testing was positive. Logistic regression models were used to determine which characteristics associate with testing and infection status. From a total of 133 children evaluated in clinic for hepatitis C from 2011 to 2021, 96.2% (128/133) were seen from 2019 to 2021. Among the 133 HCV-exposed children in our sample, 72.1% (96/133) were tested for HCV, 62.4% (83/133) were tested by PCR, 9.0% (12/133) tested by antibody, and 5.2% (5/95) of those tested were infected. Only one child out of 12 was positive for hepatitis C antibody yet, subsequent PCR testing was negative in this child. Among all five hepatitis C infected children, four were diagnosed with neonatal abstinence syndrome, five had maternal history of illicit drug use, one had maternal history of HIV infection, and all of them were identified after the hepatitis C program open in 2019. The odds of a child being tested were lower for those accompanied by their biological mother at their clinic visit (odds ratio, 0.16; 95% CI, 0.06-0.45). Screening programs on hepatitis C vertical transmission improved detection of hepatitis C among exposed children. The proportion of children born to mothers with hepatitis C in Western New York that were positive for hepatitis C was 5.2%, suggesting that similar proportion of exposed infants born before 2019 were lost for follow up.
Sections du résumé
BACKGROUND
BACKGROUND
Vertical transmission of hepatitis C virus (HCV) is the primary cause of hepatitis C in the pediatric population. Nonetheless, only a small proportion of HCV-exposed children are tested. This study aimed to measure the proportion of HCV-exposed children tested and infected in Western New York and to identify factors influencing the odds of testing and infection in this population.
METHODS
METHODS
This was a 11-year retrospective chart review study in which clinical, demographic, and behavioral data for HCV-exposed children and their mothers were collected. This period included year 2019 when a hepatitis C program began promoting early hepatitis C screening among infants born to mothers positive for hepatitis C. PCR-based detection of hepatitis C was used for children under 18 months of age and antibody testing for children above 18 months of age, followed by PCR if the antibody testing was positive. Logistic regression models were used to determine which characteristics associate with testing and infection status.
RESULTS
RESULTS
From a total of 133 children evaluated in clinic for hepatitis C from 2011 to 2021, 96.2% (128/133) were seen from 2019 to 2021. Among the 133 HCV-exposed children in our sample, 72.1% (96/133) were tested for HCV, 62.4% (83/133) were tested by PCR, 9.0% (12/133) tested by antibody, and 5.2% (5/95) of those tested were infected. Only one child out of 12 was positive for hepatitis C antibody yet, subsequent PCR testing was negative in this child. Among all five hepatitis C infected children, four were diagnosed with neonatal abstinence syndrome, five had maternal history of illicit drug use, one had maternal history of HIV infection, and all of them were identified after the hepatitis C program open in 2019. The odds of a child being tested were lower for those accompanied by their biological mother at their clinic visit (odds ratio, 0.16; 95% CI, 0.06-0.45).
CONCLUSIONS
CONCLUSIONS
Screening programs on hepatitis C vertical transmission improved detection of hepatitis C among exposed children. The proportion of children born to mothers with hepatitis C in Western New York that were positive for hepatitis C was 5.2%, suggesting that similar proportion of exposed infants born before 2019 were lost for follow up.
Identifiants
pubmed: 37460966
doi: 10.1186/s12876-023-02871-8
pii: 10.1186/s12876-023-02871-8
pmc: PMC10353113
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
242Informations de copyright
© 2023. The Author(s).
Références
J Pediatr. 2018 Dec;203:34-40.e1
pubmed: 30170857
J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):838-55
pubmed: 22487950
Curr Pediatr Rev. 2022;19(1):21-33
pubmed: 35440312
Lancet Infect Dis. 2006 Feb;6(2):83-90
pubmed: 16439328
Lancet. 2016 May 7;387(10031):1967-8
pubmed: 27203660
MMWR Morb Mortal Wkly Rep. 2017 Oct 27;66(42):1136-1139
pubmed: 29072864
Pediatrics. 1998 Aug;102(2 Pt 1):355-9
pubmed: 9685438
Clin Perinatol. 2021 Jun;48(2):343-357
pubmed: 34030818
Scand J Infect Dis. 2005;37(5):350-3
pubmed: 16051571
Clin Infect Dis. 2021 Nov 2;73(9):e3340-e3346
pubmed: 32640018
Clin Infect Dis. 2014 Sep 15;59(6):765-73
pubmed: 24928290
J Neonatal Perinatal Med. 2021;14(1):123-129
pubmed: 32039866
Liver Int. 2017 Apr;37(4):529-533
pubmed: 27125252
Arch Gynecol Obstet. 2011 Feb;283(2):255-60
pubmed: 20652289
Int J Med Sci. 2006;3(2):47-52
pubmed: 16614742
J Med Virol. 2006 Feb;78(2):305-10
pubmed: 16372293
Cells. 2019 Apr 25;8(4):
pubmed: 31027278
Open Forum Infect Dis. 2020 Oct 23;7(11):ofaa514
pubmed: 33241070
Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):294-6
pubmed: 22521559
J Matern Fetal Neonatal Med. 2014 May;27(7):664-70
pubmed: 23971940
J Infect Dis. 2005 Dec 1;192(11):1880-9
pubmed: 16267758